|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMFA02000486
|
|
7S,8S-dihydroxy-13-oxo-octadeca-9E,11E-dienoic acid
|
FA 18:3;O3
|
C18H30O5
|
326.209326
|
|
LMFA02000487
|
7R,8R-dihydroxyoleic acid
|
7R,8R-dihydroxyoctadec-9Z-enoic acid
|
FA 18:1;O2
|
C18H34O4
|
314.245711
|
|
LMFA02000488
|
13-HOTrE-d5
|
13-OH-9Z,11E,15Z-octadecatrienoic-17,17,18,18,18-d5 acid
|
|
C18H25D5O3
|
299.250879
|
|
LMFA02000490
|
9,12,13-TriHOME-[13C]3
|
9S,12S,13S-trihydroxy-10E-octadecenoic acid-[13C]3
|
|
C15[13C]3H34O5
|
333.250691
|
|
LMFA03080028
|
(+/-)14,15-EpETrE-d11
|
14,15-epoxy-5Z,8Z,11Z-eicosatrienoic-16,16,17,17,18,18,19,19,20,20,20-d11 acid
|
|
C20H21D11O3
|
331.304190
|
|
LMFA04040008
|
17(R)-Neuroprotectin D1
|
10R,17R-dihydroxy-4Z,7Z,11E,13E,15Z,19Z-docosahexaenoic acid
|
FA 22:6;O2
|
C22H32O4
|
360.230061
|
|
LMFA03050036
|
12S-HETrE
|
12S-hydroxy-8Z,10E,14Z-eicosatrienoic acid
|
|
C20H34O3
|
322.250796
|
|
LMFA04000109
|
17-oxo-DPA
|
17-oxo-7Z,10Z,13Z,15E,19Z-docosapentaenoic acid
|
FA 22:6;O
|
C22H32O3
|
344.235146
|
|
LMFA04000110
|
(+/-)19(20)-DiHDTE
|
19,20-dihydroxydocosa-7Z,10Z,13Z,16Z-tetraenoic acid
|
FA 22:4;O2
|
C22H36O4
|
364.261361
|
|
LMFA04000111
|
(+/-)19(20)-EpDTE
|
19,20-epoxydocosa-7Z,10Z,13Z,16Z-tetraenoic acid
|
FA 22:5;O
|
C22H34O3
|
346.250796
|
|
LMFA04000112
|
(+/-)7(8)-EpDTE
|
7,8-epoxydocosa-7Z,10Z,13Z,16Z-tetraenoic acid
|
FA 22:5;O
|
C22H34O3
|
346.250796
|
|
LMFA04000113
|
(+/-)7(8)-DiHDTE
|
7,8-dihydroxydocosa-7Z,10Z,13Z,16Z-tetraenoic acid
|
FA 22:4;O2
|
C22H36O4
|
364.261361
|
|
LMFA03000037
|
(+/-)14(15)-EpEDE
|
(+/-)14,15-epoxy-8Z,11Z-eicosadienoic Acid
|
FA 20:3;O
|
C20H34O3
|
322.250796
|
|
LMFA04000116
|
(+/-)13,14-DiHDoTrE
|
13,14-dihydroxy-7Z,10Z,16Z-docosatrienoic acid
|
FA 22:3;O2
|
C22H38O4
|
366.277011
|
|
LMFA04000117
|
(+/-)13,14-EDT
|
13,14-epoxy-7Z,10Z,16Z-docosatrienoic acid
|
FA 22:4;O
|
C22H36O3
|
348.266446
|
|
LMFA04000118
|
|
3-Hydroxy-7Z,10Z,13Z,16Z,19Z-docosapentaenoic acid
|
FA 22:5;O
|
C22H34O3
|
346.250796
|
|
LMFA04000119
|
17-oxo-DPE (DPA n6)
|
17-oxo-4Z,7Z,10Z,13Z,15E-docosapentaenoic acid
|
FA 22:6;O
|
C22H32O3
|
344.235146
|
|
LMFA04000120
|
17S-HDPE (DPA n6)
|
17S-hydroxy-4Z,7Z,10Z,13Z,15E-docosapentaenoic acid
|
FA 22:5;O
|
C22H34O3
|
346.250796
|
|
LMFA04000121
|
17S-HDPE (DPA n3)
|
17S-hydroxy-7Z,10Z,13Z,15E,19Z-docosapentaenoic acid
|
FA 22:5;O
|
C22H34O3
|
346.250796
|
|
LMFA03110357
|
18-epi-18-F3t-IsoP
|
12S,14R,18R-trihydroxy-5Z,8Z,13E-prostatrienoic acid-cyclo[11S,15S]
|
FA 20:4;O3
|
C20H32O5
|
352.224976
|
|
LMFA03110358
|
Tetranor-4R-4-F4t-NeuroP
|
(5Z,8Z)-10-((1S,2R,3R,5S)-3,5-dihydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)deca-5,8-dienoic acid
|
FA 19:4;O3
|
C19H30O5
|
338.209326
|
|
LMFA02030081
|
9-keto-9-L1-PhytoP
|
(E)-11-(2-ethyl-3-oxocyclopent-1-en-1-yl)-9-oxoundec-10-enoic acid
|
FA 18:5;O2
|
C18H26O4
|
306.183110
|
|
LMFA03050037
|
12S-HETrE
|
12S-hydroxy-5Z,8Z,12Z-eicosatrienoic acid
|
FA 20:3;O
|
C20H34O3
|
322.250796
|
|
LMFA03110361
|
5-epe-F3t-IsoP
|
(E,5R)-7-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(2Z,5Z)-octa-2,5-dienyl]cyclopentyl]-5-hydroxyhept-6-enoic acid
|
FA 20:4;O3
|
C20H32O5
|
352.224976
|
|
LMFA03110362
|
18-F3t-IsoP
|
12S,14R,18S-trihydroxy-5Z,8Z,13E-prostatrienoic acid-cyclo[11S,15S]
|
FA 20:4;O3
|
C20H32O5
|
352.224976
|
|
LMFA04020529
|
17(RS)-10-epi-SC-D15-11-dihomo-IsoF
|
(R,Z)-10-hydroxy-10-((2S,4S,5S)-4-hydroxy-5-((E)-3-hydroxyoct-1-en-1-yl)tetrahydrofuran-2-yl)dec-7-enoic acid
|
FA 22:3;O4
|
C22H38O6
|
398.266841
|
|
LMFA04020530
|
7(RS)-ST-delta8-11-dihomo-IsoF
|
(10S,E)-7,10-dihydroxy-10-((2S,4R,5S)-4-hydroxy-5-((Z)-oct-2-en-1-yl)tetrahydrofuran-2-yl)dec-8-enoic acid
|
FA 22:4;O4
|
C22H38O6
|
398.266841
|
|
LMFA04030020
|
Resolvin D2-d5
|
7S,16R,17S-trihydroxy-4Z,8E,10Z,12E,14E,19Z-docosahexaenoic-21,21,22,22,22-d5 acid
|
|
C22H28D5O5
|
381.256359
|
|
LMFA04010528
|
14-F3t-NeuroP-DPAomega-3
|
1a,1b-dihomo-8S,10R,14S-trihydroxy-12E,16Z,19Z-prostatrienoic acid-cyclo[7S,11R]
|
FA 22:4;O3
|
C22H36O5
|
380.256276
|
|
LMFA02030083
|
6(B)-epi-F1t-PhytoP
|
8-((1S,2S,3R,5R)-3,5-dihydroxy-2-(pentan-1-yl)cyclopentyl)-6R-hydroxy-7E-octenoic acid
|
FA 18:2;O3
|
C18H32O5
|
328.224976
|
|
LMFA04010527
|
20-F3t-NeuroP-DPAn-3
|
12-((1S,2R,3R,5S)-3,5-dihydroxy-3S-hydroxy-1E-penten-1-yl)cyclopentyl)-dodeca-7Z,10Z-dienoic acid
|
FA 22:4;O3
|
C22H36O5
|
380.256276
|
|
LMFA04010526
|
20-epi-20-F3t-NeuroP-DPAn-3
|
12-((1S,2R,3R,5S)-3,5-dihydroxy-3R-hydroxy-1E-penten-1-yl)cyclopentyl)-dodeca-7Z,10Z-dienoic acid
|
FA 22:4;O3
|
C22H36O5
|
380.256276
|
|
LMFA03060123
|
4-HETE
|
(+/-)-4-hydroxy-5Z,8Z,11Z,14Z-eicosatetraenoic acid
|
FA 20:4;O
|
C20H32O3
|
320.235146
|
|
LMFA02000489
|
13-OH-9(10)-EpOME-d5
|
9,10-epoxy-13-hydroxy-11-octadecenoic 9,10,11,12,13-d5 acid
|
|
C18H28D5O4
|
317.261444
|
|
LMFA01031365
|
|
14-Methyl-6Z-hexadecenoic acid
|
FA 17:1
|
C17H32O2
|
268.240231
|
|
LMFA01020455
|
|
13-methyl-6Z-Tetradecenoic acid
|
FA 15:1
|
C15H28O2
|
240.208930
|
|
LMFA08020455
|
Homocapsaicin II
|
6-Methyl-N-vanillyl-4E-octenamide
|
NA 17:5;O2
|
C17H25NO3
|
291.183444
|
|
LMFA08020456
|
Homocapsaicin I
|
9-Methyl-N-vanillyl-7E-decenamide
|
NA 19:5;O2
|
C19H29NO3
|
319.214744
|
|
LMFA01020457
|
16-methyl oleic acid
|
16-Methyl-9Z-octadecenoic acid
|
FA 19:1
|
C19H36O2
|
296.271531
|
|
LMFA01080040
|
|
2-methoxy-6Z-tetradecenoic acid
|
FA 15:1;O
|
C15H28O3
|
256.203846
|
|
LMFA01080041
|
|
2-methoxy-6Z-pentadecenoic acid
|
FA 16:1;O
|
C16H30O3
|
270.219496
|
|
LMFA01080042
|
|
2-methoxy-13-methyl-6Z-tetradecenoic acid
|
FA 16:1;O
|
C16H30O3
|
270.219496
|
|
LMFA02000491
|
Omphalotol C
|
13S-hydroxy-8-oxo-9E,11E-octadecadienoic acid
|
FA 18:3;O2
|
C18H30O4
|
310.214411
|
|
LMFA07040215
|
Asperbutanolide A
|
|
FA 16:5;O3
|
C16H22O5
|
294.146725
|
|
LMFA07040216
|
Asperbutanolide B
|
|
FA 16:5;O3
|
C16H22O5
|
294.146725
|
|
LMFA01031366
|
Euphormarginata acid A
|
10Z,12Z,15Z-octadecatrienoic acid
|
FA 18:3
|
C18H30O2
|
278.224581
|
|
LMFA03040014
|
Lipoxin B5
|
5S,14R,15S-trihydroxyicosa-6E,8Z,10E,12E,17Z-pentaenoic acid
|
FA 20:5;O3
|
C20H30O5
|
350.209326
|
|
LMFA03030017
|
20-hydroxy TXB2
|
9S,11,15S,20-tetrahydroxy-thromboxa-5Z,13E-dien-1-oic acid
|
FA 20:3;O5
|
C20H34O7
|
386.230456
|
|
LMFA03010049
|
PGD1
|
9S,15S-dihydroxy-11-oxo-13E-prostaenoic acid
|
FA 20:3;O3
|
C20H34O5
|
354.240626
|
|
LMFA03030018
|
11-Dehydro-13,14-dihydro-15-keto-thromboxane B2
|
9S-hydroxy-11,15-dioxo-thromboxa-5Z-en-1-oic acid
|
FA 20:4;O4
|
C20H32O6
|
368.219891
|